Article(id=1327673530298249974, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673520487772831, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.02.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1620921600000, receivedDateStr=2021-05-14, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471636603, onlineDateStr=2026-11-12, pubDate=1644422400000, pubDateStr=2022-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471636603, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471636603, creator=13701087609, updateTime=1794471636603, updator=13701087609, issue=Issue{id=1327673520487772831, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='2', pageStart='167', pageEnd='282', issueExtLink='null', onlineDate='null', pubDate='1644422400000', pubDateStr='2022-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471634265, creator='13701087609', updateTime=1794472302153, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327676322282844211, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673520487772831, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327676322282844212, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327673520487772831, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=175, endPage=183, ext={EN=ArticleExt(id=1327673532093412087, articleId=1327673530298249974, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Orally Inhaled Drug Products, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Orally inhaled drug products are a combination of aerosol generating devices with different principles and corresponding drug forms. It is the first-choice therapy for prevention and treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease(COPD). Orally inhaled drug products not only have technical challenges in the formulation development, but also have many difficulties in their use. This study summarizes the recent research progress of orally inhaled drug products in improving patient compliance, overcoming delivery dose limitations, improving atomization by controlling particle characteristics, and expanding the scope of treatment, as well as the development of relevant regulations and guidelines. The innovations in process, formulation, device, standard and treatment field are reviewed, hoping to provide some references for researches on orally inhaled products.

, authors=Chenghao LU1, 2, 3, Ali LIU1, 2, 3, Qingjuan WANG1, 2, 3, Zhong FENG1, 2, 3, Guimin ZHANG1, 2, 3, *, authorsList=Chenghao LU, Ali LIU, Qingjuan WANG, Zhong FENG, Guimin ZHANG, authorCompany=null, correspAuthors=Guimin ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327673532990993144, articleId=1327673530298249974, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=经口吸入制剂的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

经口吸入制剂是由不同原理的气溶胶发生装置与相应药物形态结合成的药械组合产品,是目前防治哮喘、慢性阻塞性肺疾病(COPD)等呼吸道疾病的首选。吸入制剂不仅制剂的研发具有技术挑战,其使用也存在诸多困难。本研究总结了国内外近年来关于经口吸入制剂在改善患者用药依从性、克服递送剂量限制、控制颗粒特性以改善雾化效果和拓展治疗领域的研究进展以及相关法规指南发展情况,综述其在工艺、处方、装置、标准及用途方面的创新情况,以期为经口吸入制剂的创新研究提供参考。

, authors=鲁成浩1, 2, 3, 刘阿利1, 2, 3, 王庆娟1, 2, 3, 冯中1, 2, 3, 张贵民1, 2, 3, *, authorsList=鲁成浩, 刘阿利, 王庆娟, 冯中, 张贵民, authorCompany=null, correspAuthors=张贵民, authorNote=

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

, correspAuthorsNote=
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=+uU0G19n7HrUWa/HngTugw==, magXml=PvSeEe4rTjyVq9HFUMGwyQ==, pdfUrl=null, pdf=qdge+aviqaO3Pogb9o13tg==, pdfFileSize=1529945, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=qbni0+SlFg3HkJbx2qOiMg==, mapNumber=null, fund=null)}, authors=[Author(id=1327673533410423555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533498503943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533410423555, language=EN, stringName=Chenghao LU, firstName=Chenghao, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673533561418504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533410423555, language=CN, stringName=鲁成浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio={"content":"

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

"}, bioImg=null, bioContent=

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673533674664714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533766939406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533674664714, language=EN, stringName=Ali LIU, firstName=Ali, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673533825659663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533674664714, language=CN, stringName=刘阿利, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673533884379921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533968266005, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533884379921, language=EN, stringName=Qingjuan WANG, firstName=Qingjuan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534047957782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533884379921, language=CN, stringName=王庆娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673534131843864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673534215729948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534131843864, language=EN, stringName=Zhong FENG, firstName=Zhong, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534278644509, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534131843864, language=CN, stringName=冯中, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673534341559071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673534412862243, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534341559071, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534467388196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534341559071, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])])], keywords=[Keyword(id=1327673534551274277, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=EN, orderNo=1, keyword=inhalation drug delivery), Keyword(id=1327673534630966054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=EN, orderNo=2, keyword=inhalation device), Keyword(id=1327673534693880615, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=EN, orderNo=3, keyword=formulation and process), Keyword(id=1327673534769378088, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=CN, orderNo=1, keyword=吸入给药), Keyword(id=1327673536438711081, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=CN, orderNo=2, keyword=吸入装置), Keyword(id=1327673536572928810, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, language=CN, orderNo=3, keyword=处方工艺)], refs=[Reference(id=1327673536669397803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MUSALE V P, JAGDALE S C.A review on validation of pharmaceutical inhalation aerosols-pressurized metered dose inhaler(pMDI)[J].Int J Res Pharm Chem, 2016, 6(2):336-344., articleTitle=null, refAbstract=null), Reference(id=1327673536786838316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=朱万辉,吴闻哲.干粉吸入制剂中粉末特性及处方模式[J].中国医药工业杂志,2018,49(6):722-729., articleTitle=null, refAbstract=null), Reference(id=1327673536870724397, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=梁超峰,卢克伟,骆慧红,等.干粉吸入剂的研究进展[J].今日药学,2019,29(4):283-288., articleTitle=null, refAbstract=null), Reference(id=1327673536942027566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Center for Drug Evaluation and Research.Nasal spray and inhalation solution, suspension, and spray drug products-chemistry, manufacturing, and controls documentation[EB/OL].[2021-11-15].https://www.fda.gov/media/70857/download., articleTitle=null, refAbstract=null), Reference(id=1327673537021719343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=高蕾,王亚敏,马玉楠,等.供雾化器用吸入液体制剂的处方和雾化装置研究[J].中国新药杂志,2018,27(18):2124-2126., articleTitle=null, refAbstract=null), Reference(id=1327673537101411120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=游一中.用于压力定量吸入气雾剂的AerosphereTM创新共悬浮递送技术[J].中华结核和呼吸杂志, 2019, 42(6):477-480., articleTitle=null, refAbstract=null), Reference(id=1327673537160131377, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=VEHRING R, LECHUGA-BALLESTEROS D, JOSHI V, et al.Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers [J].Langmuir, 2012, 28(42): 15015-15023., articleTitle=null, refAbstract=null), Reference(id=1327673537223045938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN R, ZHONG N, WANG H Y, et al.Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) formulated using co-suspension delivery technology in Chinese patients with COPD [J].Int J Chron Obstruct Pulmon Dis, 2020, 15: 43-56., articleTitle=null, refAbstract=null), Reference(id=1327673537290154803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=REISNER C, GOTTSCHLICH G, FAKIH F, et al.24-h Bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD [J].Respir Res, 2017, 18(1):157., articleTitle=null, refAbstract=null), Reference(id=1327673537348875060, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=黄桂婷,罗怡婧,帅书苑,等.纳米晶体技术在肺吸入给药中的研究进展[J].中国医院药学杂志,2020,40(23):2490-2495., articleTitle=null, refAbstract=null), Reference(id=1327673537415983925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=王珏,朱壮志,张晓红.喷雾冷冻干燥技术及其在吸入制剂中的应用[J].中国医药工业杂志,2018,49(8):1083-1090., articleTitle=null, refAbstract=null), Reference(id=1327673537483092790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SARALA N, BENGALORKAR G, BHUVANA K.Technosphere: new drug delivery system for inhaled insulin[J].Future Prescri, 2012, 13(1): 14-16., articleTitle=null, refAbstract=null), Reference(id=1327673537592144695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=何光杰,李宏,李静,等.吸入胰岛素粉雾剂Afrezza:新型抗糖尿病药[J].药物评价研究,2016,39(5):899-908., articleTitle=null, refAbstract=null), Reference(id=1327673537667642168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=WEERS J, TARARA T.The PulmoSphere™ platform for pulmonary drug delivery [J].Ther Deliv, 2014, 5(3): 277-295., articleTitle=null, refAbstract=null), Reference(id=1327673537747333945, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=WEERS J G, MILLER D P, TARARA T E.Spray-dried PulmoSphere™ formulations for inhalation comprising crystalline drug particles [J].AAPS PharmSciTech, 2019,20(3): 103., articleTitle=null, refAbstract=null), Reference(id=1327673537839608634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=JAIN H, BAIRAGI A, SRIVASTAVA S, et al.Recent advances in the development of microparticles for pulmonary administration [J].Drug Discov Today, 2020, 25(10):1865-1872., articleTitle=null, refAbstract=null), Reference(id=1327673537915106107, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM Y H, SHING K S.Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery [J].Powder Technol, 2008, 182(1): 25-32., articleTitle=null, refAbstract=null), Reference(id=1327673537990603580, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=PATOMCHAIVIWAT V, PAERATAKUL O, KULVANICH P.Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process [J].AAPS PharmSciTech, 2008, 9(4): 1119-1129., articleTitle=null, refAbstract=null), Reference(id=1327673538066101053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=REVERCHON E, PORTA G D.Micronization of antibiotics by supercritical assisted atomization [J].J Supercrit Fluids,2003, 26(3): 243-252., articleTitle=null, refAbstract=null), Reference(id=1327673538129015614, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=游一中.对我国逐步淘汰医用气雾剂所用CFCs抛射剂的建议[J].精细与专用化学品, 1999, 7(22): 32-34., articleTitle=null, refAbstract=null), Reference(id=1327673538179347263, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=金方,王彦.我国吸入气雾剂用氟里昂替代的研究现状和挑战[J].上海医药,2009,4:156-159., articleTitle=null, refAbstract=null), Reference(id=1327673538238067520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=墨西哥氟石股份公司.药物组合物:中国,109789151A[P].2019-05-21., articleTitle=null, refAbstract=null), Reference(id=1327673538296787777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=MYRDAL P B, SHETH P, STEIN S W.Advances in metered dose inhaler technology: formulation development[J].AAPS PharmSciTech, 2014, 15(2): 434-455., articleTitle=null, refAbstract=null), Reference(id=1327673538380673858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG X, YUE X, CUI Y, et al.A systematic safety evaluation of nanoporous mannitol material as a dry-powder inhalation carrier system [J].J Pharm Sci, 2020, 109(5):1692-1702., articleTitle=null, refAbstract=null), Reference(id=1327673538451977027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SMYTH H D C, HICKEY A J.Carriers in drug powder delivery [J].Am J Drug Deliv, 2005, 3: 117-132., articleTitle=null, refAbstract=null), Reference(id=1327673538519085892, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ISLAM N, CLEARY M J.Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers [J].Med Eng Phys,2012, 34(4): 409-427., articleTitle=null, refAbstract=null), Reference(id=1327673538623943493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=方孟香,张华,曹铭晨.肺部给药系统研究进展[J].医药导报,2018,37(3):302-305., articleTitle=null, refAbstract=null), Reference(id=1327673538712023878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Q, GE L, WANG L, et al.Formulation optimization and in vitro antibacterial ability investigation of azithromycin loaded FDKP microspheres dry powder inhalation [J].Chin Chem Lett, 2021, 32(3): 1071-1076., articleTitle=null, refAbstract=null), Reference(id=1327673538787521351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=RUDOKAS M, NAJLAH M, ALHNAN M A, et al.Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications[J].Med Princ Pract, 2016, 25(Suppl 2): 60-72., articleTitle=null, refAbstract=null), Reference(id=1327673538850435912, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIRLEY M.Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease [J].Drugs, 2019, 79(5): 555-562., articleTitle=null, refAbstract=null), Reference(id=1327673538938516297, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLIA A, MAHMOOD B R, FUNDORA Y, et al.Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease [J].Sr Care Pharm, 2020,35(4): 162-170., articleTitle=null, refAbstract=null), Reference(id=1327673539001430858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FAKIH F, SPANGENTHAL S, SIGAL B, et al.Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease [J].Respir Med, 2018, 138: 74-80., articleTitle=null, refAbstract=null), Reference(id=1327673539055956811, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=D'URZO A D, CAZZOLA M, HANANIA N A, et al.New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology [J].Int J Chron Obstruct Pulmon Dis, 2018, 13: 2805-2819., articleTitle=null, refAbstract=null), Reference(id=1327673539131454284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=奇斯药制品公司.格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物:中国,105848641A [P].2016-08-10., articleTitle=null, refAbstract=null), Reference(id=1327673539190174541, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=FERGUSON G T, HICKEY A J, DWIVEDI S.Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases [J].Respir Med, 2018, 134: 16-23., articleTitle=null, refAbstract=null), Reference(id=1327673539257283406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=PAPI A, VESTBO J, FABBRI L, et al.Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial [J].Lancet,2018, 391(10125): 1076-1084., articleTitle=null, refAbstract=null), Reference(id=1327673540859507535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=AGNIHOTRI V V, PARDESHI C V, SURANA S J.Chapter 11 - A current update on advanced drug delivery devices for nasal and pulmonary administration [M]// CHAPPEL E.Drug delivery devices and therapeutic systems.[s.l.]: Academic Press, 2021: 213-245., articleTitle=null, refAbstract=null), Reference(id=1327673540976948048, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=IBRAHIM M, VERMA R, GARCIA-CONTRERAS L.Inhalation drug delivery devices: technology update [J].Med Devices (Auckl), 2015, 8: 131-139., articleTitle=null, refAbstract=null), Reference(id=1327673541056639825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=张玮,丁楠,曹兆流,等.吸入装置的演变过程及研究进展[J].药学服务与研究,2021,21(1):52-56., articleTitle=null, refAbstract=null), Reference(id=1327673541207634770, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=HESS D R.Aerosol delivery devices in the treatment of asthma [J].Respir Care, 2008, 53(6): 699-723., articleTitle=null, refAbstract=null), Reference(id=1327673541320880979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=DEEKS E D, LYSENG-WILLIAMSON K A.K-haler®breath-triggered inhaler: a profile of the properties of the device [J].Drugs Ther Perspect, 2019, 35(7): 315-320., articleTitle=null, refAbstract=null), Reference(id=1327673541396378452, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=DE BOER A H, HAGEDOORN P, HOPPENTOCHT M, et al.Dry powder inhalation: past, present and future [J].Expert Opin Drug Deliv, 2017, 14(4): 499-512., articleTitle=null, refAbstract=null), Reference(id=1327673541505430357, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=钟艳,柴旭煜,王健.雾化吸入用液体制剂的研究与应用[J].世界临床药物,2020,41(3):224-231., articleTitle=null, refAbstract=null), Reference(id=1327673541622870870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=ARI A.Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes [J].Eurasian J Pulmonol, 2014, 16(1): 1-7., articleTitle=null, refAbstract=null), Reference(id=1327673541748699991, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=DHAND R.Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol [J].Respir Care,2002, 47(12): 1406-1416., articleTitle=null, refAbstract=null), Reference(id=1327673541832586072, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=MOON C, SMYTH HDC, WATTS AB, et al.Delivery technologies for orally inhaled products: an update [J].AAPS PharmSciTech, 2019, 20(3): 117., articleTitle=null, refAbstract=null), Reference(id=1327673541903889241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=MERCHANT R K, INAMDAR R, QUADE R C.Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial[J].J Allergy Clin Immunol Pract, 2016, 4(3): 455-463., articleTitle=null, refAbstract=null), Reference(id=1327673541979386714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRETT M, COMBS V, SU J G, et al.AIR Louisville: addressing asthma with technology, crowdsourcing, cross-sector collaboration, and policy [J].Health A ff (Millwood),2018, 37(4): 525-534., articleTitle=null, refAbstract=null), Reference(id=1327673542059078491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=VELAGA S P, DJURIS J, CVIJIC S, et al.Dry powder inhalers: an overview of the in vitro dissolution methodologies and their correlation with the biopharma-ceutical aspects of the drug products [J].Eur J Pharm Sci,2018, 113: 18-28., articleTitle=null, refAbstract=null), Reference(id=1327673542126187356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=高蕾,王亚敏,马玉楠,等.供雾化器用吸入液体制剂的质量研究及其综合评价[J].中国新药杂志,2019,28(3):338-340., articleTitle=null, refAbstract=null), Reference(id=1327673542231044957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=周学海,张成飞,杨敏,等.肺部吸入制剂评价方法研究进展[J].药物评价研究,2019,42(9):1891-1895., articleTitle=null, refAbstract=null), Reference(id=1327673542302348126, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=高蕾,马玉楠,王亚敏,等.吸入粉雾剂给药装置浅析及其综合评价[J].中国新药杂志,2019,28(3):335-337., articleTitle=null, refAbstract=null), Reference(id=1327673542403011423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=胡玥,盛云华,唐黎明,等.吸入制剂体内外相关性评价模型的概述[J].中国医药工业杂志,2019,50(1):34-41., articleTitle=null, refAbstract=null), Reference(id=1327673542457537376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=张继胜,黄凯,储楠楠,等.药代动力学研究在经口吸入制剂生物等效性评价中的应用进展[J].中国临床药理学与治疗学,2020,25(11):1295-1308., articleTitle=null, refAbstract=null), Reference(id=1327673542520451937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=周璇,喻勇,侯曙光.经口吸入药物生物等效性研究的科学基础与法规挑战[J].中国医药工业杂志,2021,52(9):1131-1141., articleTitle=null, refAbstract=null), Reference(id=1327673542579172194, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSIÈRE R, BERGHMANS T, DE VUYST P, et al.The position of inhaled chemotherapy in the care of patients with lung tumors: clinical feasibility and indications according to recent pharmaceutical progresses [J].Cancers (Basel),2019, 11(3): 329., articleTitle=null, refAbstract=null), Reference(id=1327673542671446883, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE W H, LOO C Y, TRAINI D, et al.Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges [J].Asian J Pharm Sci, 2015,10(6): 481-489., articleTitle=null, refAbstract=null), Reference(id=1327673542730167140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSIÈRE R, GELBCKE M, MATHIEU V, et al.New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy [J].Int J Oncol, 2015, 47(3): 1131-1142., articleTitle=null, refAbstract=null), Reference(id=1327673542801470309, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=EASA N, ALANY RG, CAREW M, et al.A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade [J].Drug Discov Today,2019, 24(2): 440-451., articleTitle=null, refAbstract=null), Reference(id=1327673542864384870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSSO G, TEOBALDI E, MAINA G.Inhaled loxapine as an option for psychomotor agitation in complex patients[J].J Clin Psychopharmacol, 2020, 40(6): 645-647., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.02.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.02.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.02.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.02.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1644422400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
经口吸入制剂的研究进展
鲁成浩 1, 2, 3 , 刘阿利 1, 2, 3 , 王庆娟 1, 2, 3 , 冯中 1, 2, 3 , 张贵民 1, 2, 3, *
中国医药工业杂志 | 综述 2022,53(2): 175-183
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (2) : 175 -183
经口吸入制剂的研究进展
全屏
[Author(id=1327673533410423555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533498503943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533410423555, language=EN, stringName=Chenghao LU, firstName=Chenghao, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673533561418504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533410423555, language=CN, stringName=鲁成浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio={"content":"

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

"}, bioImg=null, bioContent=

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673533674664714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533766939406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533674664714, language=EN, stringName=Ali LIU, firstName=Ali, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673533825659663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533674664714, language=CN, stringName=刘阿利, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673533884379921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673533968266005, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533884379921, language=EN, stringName=Qingjuan WANG, firstName=Qingjuan, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534047957782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673533884379921, language=CN, stringName=王庆娟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673534131843864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673534215729948, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534131843864, language=EN, stringName=Zhong FENG, firstName=Zhong, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534278644509, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534131843864, language=CN, stringName=冯中, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])]), Author(id=1327673534341559071, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=lunanzhangguimin@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673534412862243, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534341559071, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673534467388196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, authorId=1327673534341559071, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, *, address=1.鲁南贝特制药有限公司,山东 临沂 276006
2.国家手性制药工程技术研究中心,山东 临沂 276006
3.山东省手性制药技术创新中心,山东 临沂 276006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673533183931129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=1., ext=[AuthorCompanyExt(id=1327673533192319738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006), AuthorCompanyExt(id=1327673533196514043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533183931129, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.鲁南贝特制药有限公司,山东 临沂 276006)]), AuthorCompany(id=1327673533255234300, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=2., ext=[AuthorCompanyExt(id=1327673533259428605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533267817214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533255234300, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.国家手性制药工程技术研究中心,山东 临沂 276006)]), AuthorCompany(id=1327673533326537471, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, xref=3., ext=[AuthorCompanyExt(id=1327673533334926080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006), AuthorCompanyExt(id=1327673533339120385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673530298249974, companyId=1327673533326537471, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.山东省手性制药技术创新中心,山东 临沂 276006)])])]
鲁成浩1, 2, 3, 刘阿利1, 2, 3, 王庆娟1, 2, 3, 冯中1, 2, 3, 张贵民1, 2, 3, *
作者信息
  • 1.鲁南贝特制药有限公司,山东 临沂 276006
  • 2.国家手性制药工程技术研究中心,山东 临沂 276006
  • 3.山东省手性制药技术创新中心,山东 临沂 276006
通讯作者:
张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
作者简介:

鲁成浩(1990—),男,硕士,实验员,从事药品研发。

Advances in Orally Inhaled Drug Products
Chenghao LU1, 2, 3, Ali LIU1, 2, 3, Qingjuan WANG1, 2, 3, Zhong FENG1, 2, 3, Guimin ZHANG1, 2, 3, *
Affiliations
  • 1.Lunan Better Pharmaceutical Co., Ltd., Linyi 276006
  • 2.National Engineering and Technology Research Center of Chirality Pharmaceutical, Linyi 276006
  • 3.Shandong Technology Innovation Center of Chirality Pharmaceutical, Linyi 276006
出版时间: 2022-02-10 doi: 10.16522/j.cnki.cjph.2022.02.002
文章导航
收藏切换

经口吸入制剂是由不同原理的气溶胶发生装置与相应药物形态结合成的药械组合产品,是目前防治哮喘、慢性阻塞性肺疾病(COPD)等呼吸道疾病的首选。吸入制剂不仅制剂的研发具有技术挑战,其使用也存在诸多困难。本研究总结了国内外近年来关于经口吸入制剂在改善患者用药依从性、克服递送剂量限制、控制颗粒特性以改善雾化效果和拓展治疗领域的研究进展以及相关法规指南发展情况,综述其在工艺、处方、装置、标准及用途方面的创新情况,以期为经口吸入制剂的创新研究提供参考。

吸入给药  /  吸入装置  /  处方工艺

Orally inhaled drug products are a combination of aerosol generating devices with different principles and corresponding drug forms. It is the first-choice therapy for prevention and treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease(COPD). Orally inhaled drug products not only have technical challenges in the formulation development, but also have many difficulties in their use. This study summarizes the recent research progress of orally inhaled drug products in improving patient compliance, overcoming delivery dose limitations, improving atomization by controlling particle characteristics, and expanding the scope of treatment, as well as the development of relevant regulations and guidelines. The innovations in process, formulation, device, standard and treatment field are reviewed, hoping to provide some references for researches on orally inhaled products.

inhalation drug delivery  /  inhalation device  /  formulation and process
鲁成浩, 刘阿利, 王庆娟, 冯中, 张贵民. 经口吸入制剂的研究进展. 中国医药工业杂志, 2022 , 53 (2) : 175 -183 . DOI: 10.16522/j.cnki.cjph.2022.02.002
Chenghao LU, Ali LIU, Qingjuan WANG, Zhong FENG, Guimin ZHANG. Advances in Orally Inhaled Drug Products[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (2) : 175 -183 . DOI: 10.16522/j.cnki.cjph.2022.02.002

参考文献 引证文献
排序方式:
[1]
MUSALE V P, JAGDALE S C.A review on validation of pharmaceutical inhalation aerosols-pressurized metered dose inhaler(pMDI)[J].Int J Res Pharm Chem, 2016, 6(2):336-344.
[2]
朱万辉,吴闻哲.干粉吸入制剂中粉末特性及处方模式[J].中国医药工业杂志,2018,49(6):722-729.
[3]
梁超峰,卢克伟,骆慧红,等.干粉吸入剂的研究进展[J].今日药学,2019,29(4):283-288.
[4]
Center for Drug Evaluation and Research.Nasal spray and inhalation solution, suspension, and spray drug products-chemistry, manufacturing, and controls documentation[EB/OL].[2021-11-15].https://www.fda.gov/media/70857/download.
[5]
高蕾,王亚敏,马玉楠,等.供雾化器用吸入液体制剂的处方和雾化装置研究[J].中国新药杂志,2018,27(18):2124-2126.
[6]
游一中.用于压力定量吸入气雾剂的AerosphereTM创新共悬浮递送技术[J].中华结核和呼吸杂志, 2019, 42(6):477-480.
[7]
VEHRING R, LECHUGA-BALLESTEROS D, JOSHI V, et al.Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers [J].Langmuir, 2012, 28(42): 15015-15023.
[8]
CHEN R, ZHONG N, WANG H Y, et al.Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) formulated using co-suspension delivery technology in Chinese patients with COPD [J].Int J Chron Obstruct Pulmon Dis, 2020, 15: 43-56.
[9]
REISNER C, GOTTSCHLICH G, FAKIH F, et al.24-h Bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD [J].Respir Res, 2017, 18(1):157.
[10]
黄桂婷,罗怡婧,帅书苑,等.纳米晶体技术在肺吸入给药中的研究进展[J].中国医院药学杂志,2020,40(23):2490-2495.
[11]
王珏,朱壮志,张晓红.喷雾冷冻干燥技术及其在吸入制剂中的应用[J].中国医药工业杂志,2018,49(8):1083-1090.
[12]
SARALA N, BENGALORKAR G, BHUVANA K.Technosphere: new drug delivery system for inhaled insulin[J].Future Prescri, 2012, 13(1): 14-16.
[13]
何光杰,李宏,李静,等.吸入胰岛素粉雾剂Afrezza:新型抗糖尿病药[J].药物评价研究,2016,39(5):899-908.
[14]
WEERS J, TARARA T.The PulmoSphere™ platform for pulmonary drug delivery [J].Ther Deliv, 2014, 5(3): 277-295.
[15]
WEERS J G, MILLER D P, TARARA T E.Spray-dried PulmoSphere™ formulations for inhalation comprising crystalline drug particles [J].AAPS PharmSciTech, 2019,20(3): 103.
[16]
JAIN H, BAIRAGI A, SRIVASTAVA S, et al.Recent advances in the development of microparticles for pulmonary administration [J].Drug Discov Today, 2020, 25(10):1865-1872.
[17]
KIM Y H, SHING K S.Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery [J].Powder Technol, 2008, 182(1): 25-32.
[18]
PATOMCHAIVIWAT V, PAERATAKUL O, KULVANICH P.Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process [J].AAPS PharmSciTech, 2008, 9(4): 1119-1129.
[19]
REVERCHON E, PORTA G D.Micronization of antibiotics by supercritical assisted atomization [J].J Supercrit Fluids,2003, 26(3): 243-252.
[20]
游一中.对我国逐步淘汰医用气雾剂所用CFCs抛射剂的建议[J].精细与专用化学品, 1999, 7(22): 32-34.
[21]
金方,王彦.我国吸入气雾剂用氟里昂替代的研究现状和挑战[J].上海医药,2009,4:156-159.
[22]
墨西哥氟石股份公司.药物组合物:中国,109789151A[P].2019-05-21.
[23]
MYRDAL P B, SHETH P, STEIN S W.Advances in metered dose inhaler technology: formulation development[J].AAPS PharmSciTech, 2014, 15(2): 434-455.
[24]
ZHANG X, YUE X, CUI Y, et al.A systematic safety evaluation of nanoporous mannitol material as a dry-powder inhalation carrier system [J].J Pharm Sci, 2020, 109(5):1692-1702.
[25]
SMYTH H D C, HICKEY A J.Carriers in drug powder delivery [J].Am J Drug Deliv, 2005, 3: 117-132.
[26]
ISLAM N, CLEARY M J.Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers [J].Med Eng Phys,2012, 34(4): 409-427.
[27]
方孟香,张华,曹铭晨.肺部给药系统研究进展[J].医药导报,2018,37(3):302-305.
[28]
WANG Q, GE L, WANG L, et al.Formulation optimization and in vitro antibacterial ability investigation of azithromycin loaded FDKP microspheres dry powder inhalation [J].Chin Chem Lett, 2021, 32(3): 1071-1076.
[29]
RUDOKAS M, NAJLAH M, ALHNAN M A, et al.Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications[J].Med Princ Pract, 2016, 25(Suppl 2): 60-72.
[30]
SHIRLEY M.Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease [J].Drugs, 2019, 79(5): 555-562.
[31]
GOLIA A, MAHMOOD B R, FUNDORA Y, et al.Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease [J].Sr Care Pharm, 2020,35(4): 162-170.
[32]
FAKIH F, SPANGENTHAL S, SIGAL B, et al.Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease [J].Respir Med, 2018, 138: 74-80.
[33]
D'URZO A D, CAZZOLA M, HANANIA N A, et al.New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology [J].Int J Chron Obstruct Pulmon Dis, 2018, 13: 2805-2819.
[34]
奇斯药制品公司.格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物:中国,105848641A [P].2016-08-10.
[35]
FERGUSON G T, HICKEY A J, DWIVEDI S.Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases [J].Respir Med, 2018, 134: 16-23.
[36]
PAPI A, VESTBO J, FABBRI L, et al.Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial [J].Lancet,2018, 391(10125): 1076-1084.
[37]
AGNIHOTRI V V, PARDESHI C V, SURANA S J.Chapter 11 - A current update on advanced drug delivery devices for nasal and pulmonary administration [M]// CHAPPEL E.Drug delivery devices and therapeutic systems.[s.l.]: Academic Press, 2021: 213-245.
[38]
IBRAHIM M, VERMA R, GARCIA-CONTRERAS L.Inhalation drug delivery devices: technology update [J].Med Devices (Auckl), 2015, 8: 131-139.
[39]
张玮,丁楠,曹兆流,等.吸入装置的演变过程及研究进展[J].药学服务与研究,2021,21(1):52-56.
[40]
HESS D R.Aerosol delivery devices in the treatment of asthma [J].Respir Care, 2008, 53(6): 699-723.
[41]
DEEKS E D, LYSENG-WILLIAMSON K A.K-haler®breath-triggered inhaler: a profile of the properties of the device [J].Drugs Ther Perspect, 2019, 35(7): 315-320.
[42]
DE BOER A H, HAGEDOORN P, HOPPENTOCHT M, et al.Dry powder inhalation: past, present and future [J].Expert Opin Drug Deliv, 2017, 14(4): 499-512.
[43]
钟艳,柴旭煜,王健.雾化吸入用液体制剂的研究与应用[J].世界临床药物,2020,41(3):224-231.
[44]
ARI A.Jet, ultrasonic, and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes [J].Eurasian J Pulmonol, 2014, 16(1): 1-7.
[45]
DHAND R.Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol [J].Respir Care,2002, 47(12): 1406-1416.
[46]
MOON C, SMYTH HDC, WATTS AB, et al.Delivery technologies for orally inhaled products: an update [J].AAPS PharmSciTech, 2019, 20(3): 117.
[47]
MERCHANT R K, INAMDAR R, QUADE R C.Effectiveness of population health management using the propeller health asthma platform: a randomized clinical trial[J].J Allergy Clin Immunol Pract, 2016, 4(3): 455-463.
[48]
BARRETT M, COMBS V, SU J G, et al.AIR Louisville: addressing asthma with technology, crowdsourcing, cross-sector collaboration, and policy [J].Health A ff (Millwood),2018, 37(4): 525-534.
[49]
VELAGA S P, DJURIS J, CVIJIC S, et al.Dry powder inhalers: an overview of the in vitro dissolution methodologies and their correlation with the biopharma-ceutical aspects of the drug products [J].Eur J Pharm Sci,2018, 113: 18-28.
[50]
高蕾,王亚敏,马玉楠,等.供雾化器用吸入液体制剂的质量研究及其综合评价[J].中国新药杂志,2019,28(3):338-340.
[51]
周学海,张成飞,杨敏,等.肺部吸入制剂评价方法研究进展[J].药物评价研究,2019,42(9):1891-1895.
[52]
高蕾,马玉楠,王亚敏,等.吸入粉雾剂给药装置浅析及其综合评价[J].中国新药杂志,2019,28(3):335-337.
[53]
胡玥,盛云华,唐黎明,等.吸入制剂体内外相关性评价模型的概述[J].中国医药工业杂志,2019,50(1):34-41.
[54]
张继胜,黄凯,储楠楠,等.药代动力学研究在经口吸入制剂生物等效性评价中的应用进展[J].中国临床药理学与治疗学,2020,25(11):1295-1308.
[55]
周璇,喻勇,侯曙光.经口吸入药物生物等效性研究的科学基础与法规挑战[J].中国医药工业杂志,2021,52(9):1131-1141.
[56]
ROSIÈRE R, BERGHMANS T, DE VUYST P, et al.The position of inhaled chemotherapy in the care of patients with lung tumors: clinical feasibility and indications according to recent pharmaceutical progresses [J].Cancers (Basel),2019, 11(3): 329.
[57]
LEE W H, LOO C Y, TRAINI D, et al.Inhalation of nanoparticle-based drug for lung cancer treatment: advantages and challenges [J].Asian J Pharm Sci, 2015,10(6): 481-489.
[58]
ROSIÈRE R, GELBCKE M, MATHIEU V, et al.New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy [J].Int J Oncol, 2015, 47(3): 1131-1142.
[59]
EASA N, ALANY RG, CAREW M, et al.A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade [J].Drug Discov Today,2019, 24(2): 440-451.
[60]
ROSSO G, TEOBALDI E, MAINA G.Inhaled loxapine as an option for psychomotor agitation in complex patients[J].J Clin Psychopharmacol, 2020, 40(6): 645-647.
2022年第53卷第2期
72
17
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.02.002
  • 接收时间:2021-05-14
  • 首发时间:2026-11-12
  • 出版时间:2022-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-05-14
基金
作者信息
    1.鲁南贝特制药有限公司,山东 临沂 276006
    2.国家手性制药工程技术研究中心,山东 临沂 276006
    3.山东省手性制药技术创新中心,山东 临沂 276006

通讯作者:

张贵民(1969—),男,研究员,从事药物研发及工程化研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.02.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏